Risk factors

Aldeyra Therapeutics (ALDX) risk factors

Item 1A of every Aldeyra Therapeutics, Inc. 10-K on file, and what changed from one year to the next.

Open ALDX in Gloomberb →
  • FY2025 10-K risk factors

    112 risks, 11 new, 8 dropped, 14 reworded since the prior year. Aldeyra added 11 new risk factors focusing on FDA transparency shifts, financing dependencies on AbbVie, R&D tax changes, and cyber threats.

    Filed Feb 27, 2026
  • FY2024 10-K risk factors

    109 risks. Aldeyra Therapeutics faces significant risks from reliance on clinical trials, financing needs, manufacturing complexities, and regulatory approvals for product candidates like reproxalap.

    Filed Feb 28, 2025